Bills › 88th General Assembly
HF 2551Died when the session ended · February 25, 2020
Relating to price transparency for prescription drugs and cost-sharing calculations by carriers, and including applicability provisions
Sponsored by the House Commerce Committee
Topics:Health careInsurance
Same legislation: HF 2253
Where it is now
- Done: IntroducedFebruary 5, 2020
- Done: SubcommitteeFebruary 6, 2020
- Done: House committeeFebruary 19, 2020
- Stopped: Passes the HouseDied when the General Assembly ended
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Died when the session ended The 2020 session adjourned on June 14, 2020, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?
Amendments · 2
0 adopted · 0 failed · 2 never voted on. Newest first.
- H-8151 · filed March 11, 2020 byNever voted onAI summary This amendment requires drug manufacturers to report their total marketing and advertising costs in their annual reports. It also adds specific legal definitions for "interchangeable biological product" and "specialty drug" to be used in the bill. Its wording →
- H-8131 · filed March 10, 2020 byNever voted onAI summary This amendment adds rules for how the insurance commissioner can enforce the law against drug manufacturers and health insurance companies. It allows the commissioner to issue orders to stop illegal practices and establishes specific fines and penalties for those who violate these orders. Its wording →